<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PubTator</source><date>2020-12-04</date><key>BioC.key</key>
<document><id>25589620</id><passage><infon key="type">title</infon><offset>0</offset><text>Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.</text></passage><passage><infon key="type">abstract</infon><offset>159</offset><text>PURPOSE: We tested whether 18 polymorphisms in 16 genes (GSTP1, COX2, IL10, EGFR, EGF, FGFR4, CCDN1, VEGFR2, VEGF, CXCR2, IL8, MMP3, ICAM1, ERCC1, RAD51, and XRCC3) would predict disease-free survival (DFS), overall survival (OS), and toxicity in the INT0144 trial, which was designed to investigate different postoperative regimens of 5-fluorouracil (5-FU)-based chemoradiation (CRT) in locally advanced rectal cancers: Arm 1 consisted of bolus 5-FU followed by 5-FU protracted venous infusion (PVI) with radiotherapy; arm 2 was induction and concomitant PVI 5-FU with radiotherapy and arm 3 was induction and concomitant bolus 5-FU with radiotherapy. EXPERIMENTAL DESIGN: DNA from 746 stage II/III rectal patients enrolled in the Southwest Oncology Group (SWOG) S9304 phase III trial was analyzed. Genomic DNA was extracted from formalin-fixed, paraffin-embedded (FFPE) tumor tissue. The polymorphisms were analyzed using direct DNA-sequencing or polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). RESULTS: GSTP1-Ile105Val (rs1695) was significantly associated with DFS and OS and its effect did not vary by treatment arm. The five-year DFS and OS were 53% and 58%, respectively, for G/G, 66% and 72% for G/A, and 57% and 66% for A/A patients. In arm 2, IL8-251A/A genotype (rs4073) was associated with a lower risk of toxicities (P = 0.04). The VEGFR2 H472Q Q/Q genotype (rs1870377) was associated with a higher risk of grade 3-5 proximal upper gastrointestinal tract (PUGIT) mucositis (P = 0.04) in arm 2. However, in arm 1, this genotype was associated with a lower risk of PUGIT mucositis (P = 0.004). CONCLUSION: rs1695 may be prognostic in patients with rectal cancer treated with adjuvant CRT. rs4073 and rs1870377 may exhibit different associations with toxicity, according to the 5-FU schedule.</text><annotation id="0"><infon key="NCBI Gene identifier">2950</infon><infon key="type">Gene</infon><location offset="216" length="5"/><text>GSTP1</text></annotation><annotation id="1"><infon key="NCBI Gene identifier">4513</infon><infon key="type">Gene</infon><location offset="223" length="4"/><text>COX2</text></annotation><annotation id="2"><infon key="NCBI Gene identifier">3586</infon><infon key="type">Gene</infon><location offset="229" length="4"/><text>IL10</text></annotation><annotation id="3"><infon key="NCBI Gene identifier">1956</infon><infon key="type">Gene</infon><location offset="235" length="4"/><text>EGFR</text></annotation><annotation id="4"><infon key="NCBI Gene identifier">1950</infon><infon key="type">Gene</infon><location offset="241" length="3"/><text>EGF</text></annotation><annotation id="5"><infon key="NCBI Gene identifier">2264</infon><infon key="type">Gene</infon><location offset="246" length="5"/><text>FGFR4</text></annotation><annotation id="6"><infon key="NCBI Gene identifier">595</infon><infon key="type">Gene</infon><location offset="253" length="5"/><text>CCDN1</text></annotation><annotation id="7"><infon key="NCBI Gene identifier">3791</infon><infon key="type">Gene</infon><location offset="260" length="6"/><text>VEGFR2</text></annotation><annotation id="8"><infon key="code">222</infon><infon key="NCBI Gene identifier">7422</infon><infon key="type">Gene</infon><location offset="268" length="4"/><text>VEGF</text></annotation><annotation id="9"><infon key="NCBI Gene identifier">3579</infon><infon key="type">Gene</infon><location offset="274" length="5"/><text>CXCR2</text></annotation><annotation id="10"><infon key="NCBI Gene identifier">3576</infon><infon key="type">Gene</infon><location offset="281" length="3"/><text>IL8</text></annotation><annotation id="11"><infon key="NCBI Gene identifier">4314</infon><infon key="type">Gene</infon><location offset="286" length="4"/><text>MMP3</text></annotation><annotation id="12"><infon key="NCBI Gene identifier">3383</infon><infon key="type">Gene</infon><location offset="292" length="5"/><text>ICAM1</text></annotation><annotation id="13"><infon key="NCBI Gene identifier">2067</infon><infon key="type">Gene</infon><location offset="299" length="5"/><text>ERCC1</text></annotation><annotation id="14"><infon key="NCBI Gene identifier">5888</infon><infon key="type">Gene</infon><location offset="306" length="5"/><text>RAD51</text></annotation><annotation id="15"><infon key="NCBI Gene identifier">7517</infon><infon key="type">Gene</infon><location offset="317" length="5"/><text>XRCC3</text></annotation><annotation id="16"><infon key="NCBI Gene identifier">2950</infon><infon key="type">Gene</infon><location offset="1196" length="5"/><text>GSTP1</text></annotation><annotation id="17"><infon key="NCBI Gene identifier">3576</infon><infon key="type">Gene</infon><location offset="1443" length="3"/><text>IL8</text></annotation><annotation id="18"><infon key="NCBI Gene identifier">3791</infon><infon key="type">Gene</infon><location offset="1535" length="6"/><text>VEGFR2</text></annotation></passage></document>
</collection>
